trading up 4.5%...waiting for full targets

buying small quantity of AMDL

AMDL is 2x Bull Etf of AMD stock

Buying some OTIS share at close

Saral Analyst Updates and Price Targets:
$DKNG
- DraftKings - Freedom Broker initiates with Buy, sets PT at $30 - Freedom Broker
$PLTR
- Palantir - Rosenblatt reiterates Buy, maintains PT at $225 - Rosenblatt
$INTC
- Intel - Mizuho reiterates Neutral, maintains PT at $124 - Mizuho
$COST
- Costco - UBS maintains Buy, raises PT to $1,275 - UBS
$MP
- MP Materials - DA Davidson reiterates Buy, maintains PT at $82 - DA Davidson
$HUM
- Humana - Deutsche Bank upgrades to Buy, raises PT to $441 - Deutsche Bank
$VRT
- Vertiv - TD Cowen maintains Buy, raises PT to $387 - TD Cowen
$GOOGL
- Alphabet - BMO Capital reiterates Outperform, maintains PT at $435 - BMO Capital
$CRWD
- CrowdStrike - Cantor Fitzgerald maintains Overweight, raises PT to $700 - Cantor Fitzgerald
$DELL
- Dell - Bernstein upgrades PT to $280, reiterates Outperform - Bernstein Keep It Saral

Saral Bought PPLT etf

Sold all $URAA at 7%

Sold all at 10%

Saral Analyst and Price Target Updates:
$GOOG
- Alphabet — Reiterates Buy, maintains PT at $450. Sees massive AI usage growth and expanding product rollout strengthening Google’s AI ecosystem. — TD Cowen
$VRT
- Vertiv — Reiterates Outperform, maintains PT at $435 ('Hyper-Growth with a Bull Case'). Sees AI datacenter demand driving sustained hyper-growth and long-term EPS upside. — RBC Capital
$APLD
- Applied Digital — Maintains Buy, raises PT to $66. Sees rapid hyperscaler demand and expanding AI infrastructure pipeline driving upside. — Needham
$NVDA
- NVIDIA — Launches massive $500 PT (highest among updates; Evercore at $413 with nearly every major firm also raising targets). — Baird
$OXY
- Occidental Petroleum — Upgrades to Neutral, raises PT to $64. Sees debt reduction and improving execution strengthening OXY’s outlook. — Goldman Sachs
$ARM
- Arm — Reiterates Buy, maintains PT at $290 ('Arm To Benefit From Strong Vera Demand'). Sees hyperscaler CPU demand and AI adoption accelerating Arm’s royalty growth. — Jefferies
$VST
- Vistra — Maintains Buy, cuts PT to $190. Sees recent pullback creating compelling value opportunity, with data center exposure and contracted EBITDA supporting upside. — Jefferies

Up 5.5% selling all pre markets

Saral is Buying $MOO ETF

Saral is Buying $BRZU Etf its 2x leveraged Bull etf of Brazil index

Saral Analyst Updates and Price Targets:
$APLD
- Applied Digital Corporation - Maintains Buy recommendation and raises the price target to $70, highlighting repeated successes with major hyperscalers and rising AI infrastructure needs that demonstrate strong project execution. - Michael Donovan (Compass Point)
$BE
- Bloom Energy Corporation - Upgraded from Neutral to Outperform with a new price target of $324. - Dennis Ip (Daiwa Securities)
$EOSE
- Eos Energy Enterprises - Initiates coverage with a Buy rating and $11 price target, citing AI-driven power demand and supportive U.S. energy storage trends that should accelerate commercialization. - Needham
$HIMS
- Hims & Hers Health, Inc. - Maintains Hold rating but raises price target to $23 based on enhanced visibility into GLP-1 revenue trends using proprietary transaction data. - Truist
$OKLO
- Oklo Inc. - Initiates coverage with Buy rating and $80 price target, recognizing the vertically integrated small modular reactor model as a leading position in the industry. - BofA
$PLTR
- Palantir Technologies - Reiterates Neutral rating and $138 price target while noting expanding leadership in AI orchestration solutions for enterprise and government clients. - Thomas Blakey (Cantor Fitzgerald)
$SMR
- NuScale Power Corporation - Initiates with Neutral rating and $12 price target, balancing strong technology against funding and execution challenges. - BofA
$UNH
- UnitedHealth Group - Raises price target to $460 from $410 while keeping Buy rating. - A.J. Rice (UBS)
$WDAY
- Workday, Inc. - Upgrades to Outperform and increases price target to $216 from $214. - Bernstein (SocGen) #LetsTradeSaral

This was $NU almost 30 peolple answered 8 got it right

Can you guess the ticker based on its financial footprint?
The Pedigree: It was founded in the late 90s by an executive who looked at a highly fragmented "junk" industry and ran the exact same corporate roll-up playbook he just used to build a global waste management empire.
The Multiple Collapse: During the 2010s, this stock was a premium compounder commanding a 20x to 30x P/E ratio. Today, the multiple has collapsed to a depressed ~10x forward P/E, sitting roughly 55% below its 2021 all-time high.
The Capital Allocation 180: It has been funneling every cent of cash flow into buying out over 200 mom-and-pop competitors. Then, right at its peak, it flipped its DNA. It now yields over 4%.
The Catalyst: It actually benefits when consumers are too stretched to afford brand-new things. Yet, despite projecting over $700M in free cash flow this year, the market refuses to bid it up. Frustrated, the Board just pulled the ultimate corporate lever: bringing in the bankers for a "comprehensive review of strategic alternatives."

Guess this company and get 2 months FREE trial. First 2 people only. Not to be mixed with any other offer. DM at 469 897 2255

Its LKQ 4 people answered 2 got it right.

$LKQ is currently exhibiting classic turnaround signals. Technology: The stock has reached a new 12-month low, establishing a potential deep-value entry point. Fundamentals: Revenue increased by 4.3% year-over-year ($3.47 billion) with FY26 EPS guided to $2.90-$3.20. Dividend: Offers a solid yield of approximately 4.3% while awaiting recovery. Catalyst: Management is aggressively simplifying the portfolio to focus on core value creation.

Saral may start buying on Monday..!